Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Endostatin enters phase II trial in stage IV metastatic melanoma

May 30, 2002

Eligard 7.5 mg launched for advanced prostate cancer

May 29, 2002

Data from basic and clinical studies on prostate cancer reported at AUA

May 29, 2002

Antitumor effects of COX and 5-LO inhibitors under evaluation by several research groups

May 29, 2002

New approaches to bladder cancer management discussed in Orlando this week

May 29, 2002

Medarex acquires anticancer and immunotherapeutic programs from Corixa

May 29, 2002

Novel dual mechanism of action reported for CP-248

May 29, 2002

CCI-779 well tolerated and active in renal cell carcinoma

May 28, 2002

CKD-602 evaluated clinically as a treatment for solid tumors

May 28, 2002

Novel epothilone examined for pharmacokinetic behavior in phase I trial

May 28, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...